au.\*:("CANONICA, G. W")
Results 1 to 25 of 159
Selection :
ICAM-1 et inflammation allergique : Preventia : l'étude respiratoire = ICAM-1 and allergic inflammation : International Study of preventionCANONICA, G. W.Allergie et immunologie (Paris). 1997, Vol 29, Num 3, pp 77-79, issn 0397-9148Article
Incidence of digestive diseases in patients with adverse reactions to foodsCIPRANDI, G; CANONICA, G. W.Annals of allergy. 1988, Vol 61, Num 5, pp 334-336, issn 0003-4738Article
Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategiesCANONICA, G. W; COMPALATI, E.Clinical and experimental immunology (Print). 2009, Vol 158, Num 3, pp 260-271, issn 0009-9104, 12 p.Article
Treating the allergic patient: think globally, treat globallyPASSALACQUA, G; CANONICA, G. W.Allergy (Copenhagen). 2002, Vol 57, Num 10, pp 876-883, issn 0105-4538Article
Minimal persistent inflammation may be controlled by cetirizine : Allergy at the Turn of the Century Review on CetirizineCANONICA, G. W; CIPRANDI, G.Annals of allergy, asthma, & immunology. 1999, Vol 83, Num 5, pp 445-448, issn 1081-1206Article
Alternative routes for allergen-specific immunotherapyPASSALACQUA, G; CANONICA, G. W.Journal of investigational allergology & clinical immunology. 1996, Vol 6, Num 2, pp 81-87, issn 1018-9068Article
The perception of allergen-specific immunotherapy among chest physicians: an Italian surveyLOMBARDI, C; CANONICA, G. W; PASSALACQUA, G et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 4, pp 132-136, issn 1764-1489, 5 p.Article
Sublingual immunotherapy in the treatment of adult allergic rhinitis patientsCANONICA, G. W; PASSALACQUA, G.Allergy. Supplement. 2006, Vol 61, Num 81, pp 20-23, issn 0108-1675, 4 p.Article
Sublingual IT in OASLOMBARDI, C; CANONICA, G. W; PASSALACQUA, G et al.Allergy (Copenhagen). 2000, Vol 55, Num 7, pp 677-678, issn 0105-4538Article
Cost-effectiveness of GRAZAX® for prevention of grass pollen induced rhinoconjunctivitis in Southern EuropeCANONICA, G. W; POULSER, P. B; VESTENBAEK, U et al.Respiratory medicine. 2007, Vol 101, Num 9, pp 1885-1894, issn 0954-6111, 10 p.Article
Sleep disturbances in allergic diseases : Rhinitis: not always allergicBAIARDINI, I; BRAIDO, F; CAUGLIA, S et al.Allergy (Copenhagen). 2006, Vol 61, Num 11, pp 1259-1267, issn 0105-4538, 9 p.Article
Effects of Mizolastine in vitro on human immunocompetent and airway cells: Evidence for safety and additional propertyODDERA, S; CAGNONI, F; DELLACASA, P et al.International archives of allergy and immunology. 2000, Vol 123, Num 2, pp 162-169, issn 1018-2438Article
Allergen-specific conjunctival challenge in asthma : An additional diagnostic tool to define sensitizationCIPRANDI, G; BUSCAGLIA, S; SCORDAMAGLIA, A et al.International archives of allergy and immunology. 1997, Vol 112, Num 3, pp 247-252, issn 1018-2438Article
Drug treatment of allergic conjunctivitis : a review of the evidenceCIPRANDI, G; BUSCAGLIA, S; CERQUETI, P. M et al.Drugs (Basel). 1992, Vol 43, Num 2, pp 154-176, issn 0012-6667Article
Pharmacologic treatment of adverse reactions to foods: comparison of different protocolsCIPRANDI, G; SCORDAMAGLIA, A; BAGNASCO, M et al.Annals of allergy. 1987, Vol 58, Num 5, pp 341-343, issn 0003-4738Article
Efficacy of desloratadine in the treatment of allergic rhinitis : a meta-analysis of randomized, double-blind, controlled trials : The nose from symptoms to evidence based medicineCANONICA, G. W; TARANTINI, F; COMPALATI, E et al.Allergy (Copenhagen). 2007, Vol 62, Num 4, pp 359-366, issn 0105-4538, 8 p.Article
Protective effect of different doses of terfenadine on the conjunctival provocation testCIPRANDI, G; BUSCAGLIA, S; IUDICE, A et al.Allergy, European journal of allergy and clinical immunology. 1992, Vol 47, Num 4, pp 309-312, p.1Article
The perception of allergen-specific immunotherapy among Italian general practitionersLOMBARDI, C; BETTONCELLI, G; CANONICA, G. W et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 2, pp 83-86, issn 1764-1489, 4 p.Article
Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitisMILANESE, M; RICCA, V; CANONICA, G.-W et al.European annals of allergy and clinical immunology. 2005, Vol 37, Num 1, pp 7-10, issn 1764-1489, 4 p.Article
Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergyTOSCA, M; CIPRANDI, G; PASSALACQUA, G et al.Journal of investigational allergology & clinical immunology. 1998, Vol 8, Num 1, pp 23-26, issn 1018-9068Article
European academy of allergology and clinical immunology (EAACI) guidelines for continuing medical education : Essentials for accreditation, standards for commercial support, and system of creditsBUSCAGLIA, S; PALMA-CARLOS, A. G; CANONICA, G. W et al.Allergy (Copenhagen). 1997, Vol 52, Num 5, pp 490-503, issn 0105-4538Article
The perception of allergen-specific immunotherapy among italian general practitionersLOMBARDI, C; BETTONCELLI, G; CANONICA, G. W et al.European annals of allergy and clinical immunology. 2012, Vol 44, Num 2, pp 80-82, issn 1764-1489, 3 p.Article
The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA 2LEN meta-analysisCOMPALATI, E; PASSALACQUA, G; BONINI, M et al.Allergy (Copenhagen). 2009, Vol 64, Num 11, pp 1570-1579, issn 0105-4538, 10 p.Article
Sublingual immunotherapy: certainties, unmet needs and future directionsPASSALACQUA, G; LOMBARDI, C; TROISE, C et al.European annals of allergy and clinical immunology. 2009, Vol 41, Num 6, pp 163-170, issn 1764-1489, 8 p.Article
Rhinitis, rhinosinusitis and quality of life in childrenPASSALACQUA, G; CANONICA, G. W; BAIARDINI, I et al.Pediatric allergy and immunology. Supplementum. 2007, Vol 18, Num 18, pp 40-45, issn 0906-5784, 6 p.Article